$VATE
INNOVATE Corp. Stock $vate

$vate Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000100683724000122 Filed on August 07, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$242.2M	$313.1M
YoY Change	-35.46%	-15.1%
Cost Of Revenue	$194.0M	$247.5M
YoY Change	-38.72%	-21.73%
Gross Profit	$48.20M	$65.60M
YoY Change	-17.89%	24.71%
Gross Profit Margin	19.9%	20.95%
Selling, General & Admin	$37.40M	$42.90M
YoY Change	-14.61%	4.38%
% of Gross Profit	77.59%	65.4%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$6.100M	$6.400M
YoY Change	0.0%	3.23%
% of Gross Profit	12.66%	9.76%
Operating Expenses	$37.40M	$42.90M
YoY Change	-14.61%	4.38%
Operating Profit	$5.900M	$28.80M
YoY Change	-44.86%	396.55%
Interest Expense	-$21.20M	-$17.60M
YoY Change	-223.98%	-207.98%
% of Operating Profit	-359.32%	-61.11%
Other Income/Expense, Net	$2.200M	$200.0K
YoY Change	450.0%	-33.33%
Pretax Income	-$13.10M	$11.40M
YoY Change	74.67%	-208.57%
Income Tax	$3.100M	-$2.500M
% Of Pretax Income		-21.93%
Net Earnings	-$15.00M	$14.40M
YoY Change	114.29%	-245.45%
Net Earnings / Revenue	-6.19%	4.6%
Basic Earnings Per Share	-$1.18	$0.11
Diluted Earnings Per Share	-$1.18	$0.10
COMMON SHARES
Basic Shares Outstanding	130.5M shares	85.19M shares
Diluted Shares Outstanding	12.97M shares	144.3M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$51.00M	$80.20M
YoY Change	-8.44%	178.47%
Cash & Equivalents	$51.00M	$80.20M
Short-Term Investments
Other Short-Term Assets	$16.00M	$14.40M
YoY Change	-2.44%	5.88%
Inventory	$21.00M	$20.90M
Prepaid Expenses	$10.60M	$8.000M
Receivables	$190.8M	$178.2M
Other Receivables	$3.100M	$2.600M
Total Short-Term Assets	$399.9M	$394.9M
YoY Change	-27.62%	-25.66%
LONG-TERM ASSETS
Property, Plant & Equipment	$186.0M	$192.1M
YoY Change	-15.72%	-13.59%
Goodwill	$127.1M	$127.0M
YoY Change	0.24%	0.0%
Intangibles	$173.4M	$175.1M
YoY Change	-4.09%	-4.11%
Long-Term Investments	$1.800M	$1.800M
YoY Change	-25.0%	-35.71%
Other Assets	$60.40M	$54.50M
YoY Change	-10.12%	-19.97%
Total Long-Term Assets	$497.3M	$504.0M
YoY Change	-8.52%	-8.08%
TOTAL ASSETS
Total Short-Term Assets	$399.9M	$394.9M
Total Long-Term Assets	$497.3M	$504.0M
Total Assets	$897.2M	$898.9M
YoY Change	-18.15%	-16.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$83.70M	$90.40M
YoY Change	-43.9%	-52.09%
Accrued Expenses	$93.30M	$60.10M
YoY Change	40.51%	-18.01%
Deferred Revenue	$85.50M	$72.80M
YoY Change	-47.29%	-37.94%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$189.2M	$50.20M
YoY Change	16.22%	-77.43%
Total Short-Term Liabilities	$468.0M	$289.3M
YoY Change	-16.08%	-53.26%
LONG-TERM LIABILITIES
Long-Term Debt	$502.4M	$638.3M
YoY Change	-14.38%	22.84%
Other Long-Term Liabilities	$47.80M	$77.20M
YoY Change	-36.1%	39.86%
Total Long-Term Liabilities	$47.80M	$77.20M
YoY Change	-36.1%	39.86%
TOTAL LIABILITIES
Total Short-Term Liabilities	$468.0M	$289.3M
Total Long-Term Liabilities	$47.80M	$77.20M
Total Liabilities	$1.023B	$1.009B
YoY Change	-16.39%	-15.73%
SHAREHOLDERS EQUITY
Retained Earnings	-$505.3M	-$490.3M
YoY Change	5.71%	4.1%
Common Stock	$348.4M	$348.4M
YoY Change	6.25%	6.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$163.1M	-$149.0M
YoY Change
Total Liabilities & Shareholders Equity	$897.2M	$898.9M
YoY Change	-18.15%	-16.73%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	-$15.00M	$14.40M
YoY Change	114.29%	-245.45%
Depreciation, Depletion And Amortization	$6.100M	$6.400M
YoY Change	0.0%	3.23%
Cash From Operating Activities	-$28.40M	$21.50M
YoY Change	-208.81%	32.72%
INVESTING ACTIVITIES
Capital Expenditures	$3.100M	$3.100M
YoY Change	-45.61%	-31.11%
Acquisitions
YoY Change
Other Investing Activities	-$200.0K	$5.700M
YoY Change	-200.0%
Cash From Investing Activities	-$3.300M	$2.600M
YoY Change	-40.0%	-157.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.800M	17.50M
YoY Change	-73.13%	2400.0%
NET CHANGE
Cash From Operating Activities	-28.40M	21.50M
Cash From Investing Activities	-3.300M	2.600M
Cash From Financing Activities	1.800M	17.50M
Net Change In Cash	-29.90M	41.60M
YoY Change	-209.52%	235.48%
FREE CASH FLOW
Cash From Operating Activities	-$28.40M	$21.50M
Capital Expenditures	$3.100M	$3.100M
Free Cash Flow	-$31.50M	$18.40M
YoY Change	-254.41%	57.26%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001006837
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	686700000	usd
CY2024Q2	us-gaap	Cost Of Revenue CostOfRevenue	247500000	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	316200000	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	65600000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	52600000	usd
CY2024Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	42900000	usd
CY2024Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4400000	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5600000	usd
CY2024Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	10500000	usd
CY2023Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-100000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	28800000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	5800000	usd
CY2024Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1100000	usd
CY2023Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-300000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	11400000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10500000	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	13900000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-11700000	usd
CY2024Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-500000	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1800000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	14400000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-9900000	usd
CY2024Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	300000	usd
CY2023Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	600000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-20700000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-20700000	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	89204850	shares
CY2024Q2	us-gaap	Profit Loss ProfitLoss	13900000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-11700000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	400000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-100000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-700000	usd
	vate	Other Comprehensive Income Loss Disposal Of Subsidiary Net Of Tax OtherComprehensiveIncomeLossDisposalOfSubsidiaryNetOfTax	0	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	400000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-100000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-700000	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	14300000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-11800000	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-6900000	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-500000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1800000	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-3300000	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	14800000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10000000.0	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3600000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	80200000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	80800000	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	178200000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	278400000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	20900000	usd
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	14400000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	14600000	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	394900000	usd
CY2024Q2	us-gaap	Investments Investments	1800000	usd
CY2023Q4	us-gaap	Investments Investments	1800000	usd
CY2024Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1900000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2000000.0	usd
CY2024Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	143700000	usd
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	154600000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	127000000.0	usd
CY2023Q4	us-gaap	Goodwill Goodwill	127100000	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	175100000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	178900000	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	54500000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	61300000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	153500000	usd
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	15800000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	16100000	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	289300000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	413800000	usd
CY2024Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	4300000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	4100000	usd
CY2024Q2	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	638300000	usd
CY2023Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	679300000	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	77200000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	82700000	usd
CY2024Q2	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	300000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	313100000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	368800000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	628300000	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	41100000	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	200000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	300000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2500000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1200000	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.11
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77922241	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77806010	shares
	us-gaap	Profit Loss ProfitLoss	-6200000	usd
CY2024Q2	vate	Other Comprehensive Income Loss Disposal Of Subsidiary Net Of Tax OtherComprehensiveIncomeLossDisposalOfSubsidiaryNetOfTax	0	usd
CY2023Q2	vate	Other Comprehensive Income Loss Disposal Of Subsidiary Net Of Tax OtherComprehensiveIncomeLossDisposalOfSubsidiaryNetOfTax	0	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	22400000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	517900000	usd
CY2024Q2	us-gaap	Assets Assets	898900000	usd
CY2024Q2	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	90400000	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	142900000	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	60100000	usd
CY2024Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	50200000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	30500000	usd
CY2024Q2	us-gaap	Liabilities Liabilities	1009100000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1179900000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	vate	Redeemable Noncontrolling Interest Equity Common Carrying Amount Net Of Adjustments RedeemableNoncontrollingInterestEquityCommonCarryingAmountNetOfAdjustments	-200000	usd
CY2024Q2	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	15900000	usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	15400000	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	100000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	100000	usd
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	160000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	132017923	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	80722983	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	130529931	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	79234991	shares
CY2024Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	348300000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	328200000	usd
CY2024Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	1487992	shares
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	1487992	shares
CY2024Q2	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	5400000	usd
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	5400000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-490300000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-487300000	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1700000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1100000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-149000000.0	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-165500000	usd
CY2024Q2	us-gaap	Minority Interest MinorityInterest	22900000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	13800000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-126100000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-151700000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	898900000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1043600000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	400000	usd
CY2024Q2	vate	Depreciation Depletion And Amortization Nonproduction Including Cost Of Revenue DepreciationDepletionAndAmortizationNonproductionIncludingCostOfRevenue	8300000	usd
CY2023Q2	vate	Depreciation Depletion And Amortization Nonproduction Including Cost Of Revenue DepreciationDepletionAndAmortizationNonproductionIncludingCostOfRevenue	9700000	usd
	vate	Depreciation Depletion And Amortization Nonproduction Including Cost Of Revenue DepreciationDepletionAndAmortizationNonproductionIncludingCostOfRevenue	16700000	usd
	vate	Depreciation Depletion And Amortization Nonproduction Including Cost Of Revenue DepreciationDepletionAndAmortizationNonproductionIncludingCostOfRevenue	19900000	usd
CY2024Q2	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	3100000	usd
CY2023Q2	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	4500000	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	8700000	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	8200000	usd
CY2023Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-300000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2300000	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	200000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent
CY2024Q2	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2023Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent
CY2024Q2	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
CY2024Q2	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#DebtAndCapitalLeaseObligations
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#DebtAndCapitalLeaseObligations
CY2024Q2	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent
CY2023Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent
CY2024Q2	us-gaap	Interest Expense Operating InterestExpenseOperating	16500000	usd
CY2023Q2	us-gaap	Interest Expense Operating InterestExpenseOperating	16300000	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	14100000	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	14100000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-3600000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3600000	usd
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.10
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77922241	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77806010	shares
CY2024Q2	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	101200000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	118600000	usd
CY2024Q2	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	0	usd
CY2023Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	3100000	usd
CY2023Q4	us-gaap	Assets Assets	1043600000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	70800000	usd
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	72800000	usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	vate	Redeemable Noncontrolling Interest Equity Common Carrying Amount Net Of Adjustments RedeemableNoncontrollingInterestEquityCommonCarryingAmountNetOfAdjustments	-1000000.0	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-173200000	usd
CY2024Q2	vate	Stock Issued During Period Value Rights Offering StockIssuedDuringPeriodValueRightsOffering	2400000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	31300000	usd
CY2024Q2	vate	Stockholders Equity Effect Of Convertible Preferred Stock Investments StockholdersEquityEffectOfConvertiblePreferredStockInvestments	-1100000	usd
CY2024Q2	us-gaap	Minority Interest Period Increase Decrease MinorityInterestPeriodIncreaseDecrease	100000	usd
CY2024Q2	us-gaap	Stockholders Equity Other StockholdersEquityOther	0	usd
CY2024Q2	vate	Net Income Loss Including Portion Attributableto Noncontrolling Interest Excluding Temporary Equity NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingTemporaryEquity	14100000	usd
CY2024Q2	vate	Other Comprehensive Income Loss Including Portion Attributableto Noncontrolling Interestand Redeemable Noncontrolling Interest OtherComprehensiveIncomeLossIncludingPortionAttributabletoNoncontrollingInterestandRedeemableNoncontrollingInterest	400000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-126100000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-151700000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	800000	usd
	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	600000	usd
	vate	Stock Issued During Period Value Rights Offering StockIssuedDuringPeriodValueRightsOffering	1900000	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	31300000	usd
	vate	Stockholders Equity Effect Of Convertible Preferred Stock Investments StockholdersEquityEffectOfConvertiblePreferredStockInvestments	-1100000	usd
	us-gaap	Minority Interest Period Increase Decrease MinorityInterestPeriodIncreaseDecrease	100000	usd
	us-gaap	Stockholders Equity Other StockholdersEquityOther	100000	usd
	vate	Net Income Loss Including Portion Attributableto Noncontrolling Interest Excluding Temporary Equity NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingTemporaryEquity	-5800000	usd
	vate	Other Comprehensive Income Loss Including Portion Attributableto Noncontrolling Interestand Redeemable Noncontrolling Interest OtherComprehensiveIncomeLossIncludingPortionAttributabletoNoncontrollingInterestandRedeemableNoncontrollingInterest	-700000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-126100000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-118100000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	700000	usd
CY2023Q2	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	400000	usd
CY2023Q2	us-gaap	Minority Interest Period Increase Decrease MinorityInterestPeriodIncreaseDecrease	0	usd
CY2023Q2	vate	Net Income Loss Including Portion Attributableto Noncontrolling Interest Excluding Temporary Equity NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingTemporaryEquity	-10000000.0	usd
CY2023Q2	vate	Other Comprehensive Income Loss Including Portion Attributableto Noncontrolling Interestand Redeemable Noncontrolling Interest OtherComprehensiveIncomeLossIncludingPortionAttributabletoNoncontrollingInterestandRedeemableNoncontrollingInterest	-300000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-128100000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-90600000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1200000	usd
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	100000	usd
	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	1300000	usd
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	10700000	usd
	us-gaap	Minority Interest Period Increase Decrease MinorityInterestPeriodIncreaseDecrease	-100000	usd
	vate	Net Income Loss Including Portion Attributableto Noncontrolling Interest Excluding Temporary Equity NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingTemporaryEquity	-16800000	usd
	vate	Other Comprehensive Income Loss Including Portion Attributableto Noncontrolling Interestand Redeemable Noncontrolling Interest OtherComprehensiveIncomeLossIncludingPortionAttributabletoNoncontrollingInterestandRedeemableNoncontrollingInterest	-9900000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-128100000	usd
	us-gaap	Profit Loss ProfitLoss	-6200000	usd
	us-gaap	Profit Loss ProfitLoss	-19700000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	800000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1200000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	16700000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	19900000	usd
	vate	Gain Loss On Lease Modification GainLossOnLeaseModification	7700000	usd
	vate	Gain Loss On Lease Modification GainLossOnLeaseModification	0	usd
	vate	Amortization Of Deferred Financing Costs AmortizationOfDeferredFinancingCosts	3700000	usd
	vate	Amortization Of Deferred Financing Costs AmortizationOfDeferredFinancingCosts	3300000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2200000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2300000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-4300000	usd
	vate	Equity Method Investment Realized And Unrealized Gain Loss EquityMethodInvestmentRealizedAndUnrealizedGainLoss	0	usd
	vate	Equity Method Investment Realized And Unrealized Gain Loss EquityMethodInvestmentRealizedAndUnrealizedGainLoss	16000000.0	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	200000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-5400000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	1100000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	600000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-102500000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	38300000	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-17400000	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	10200000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	300000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-1900000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1500000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1800000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-5400000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-5600000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-52700000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-22400000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-5800000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	3400000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-80700000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	18700000	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	800000	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-3200000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-2900000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-1500000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3900000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-60800000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8700000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8200000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	9800000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	300000	usd
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	2300000	usd
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	usd
	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0	usd
	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	54200000	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-500000	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-400000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-700000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	46700000	usd
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	33200000	usd
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	20000000.0	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	75000000.0	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	50000000.0	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	77000000.0	usd
	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	24800000	usd
	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	3600000	usd
	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	22800000	usd
	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	14200000	usd
	us-gaap	Payments For Repurchase Of Redeemable Preferred Stock PaymentsForRepurchaseOfRedeemablePreferredStock	0	usd
	us-gaap	Payments For Repurchase Of Redeemable Preferred Stock PaymentsForRepurchaseOfRedeemablePreferredStock	7000000.0	usd
	vate	Payments To Noncontrolling Interest And Redeemable Noncontrolling Interests Sale Of Equity Method Investments PaymentsToNoncontrollingInterestAndRedeemableNoncontrollingInterestsSaleOfEquityMethodInvestments	0	usd
	vate	Payments To Noncontrolling Interest And Redeemable Noncontrolling Interests Sale Of Equity Method Investments PaymentsToNoncontrollingInterestAndRedeemableNoncontrollingInterestsSaleOfEquityMethodInvestments	15900000	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	600000	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	1600000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-200000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4600000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-37300000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-600000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-600000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-600000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-52000000.0	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	82300000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	82200000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	81700000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	30200000	usd
	us-gaap	Nature Of Operations NatureOfOperations	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1. Organization and Business </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">INNOVATE Corp. ("INNOVATE" and, together with its consolidated subsidiaries, the "Company", "we" and "our") is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments. We seek to grow these businesses so that they can generate long-term sustainable free cash flow and attractive returns in order to maximize value for all stakeholders. While the Company generally intends to acquire controlling equity interests in its operating subsidiaries, the Company may invest to a limited extent in a variety of non-controlling equity interest positions or debt instruments. The Company’s shares of common stock trade on the New York Stock Exchange ("NYSE") under the symbol "VATE".</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company currently has three reportable segments, plus our Other segment, based on management’s organization of the enterprise: Infrastructure, Life Sciences, Spectrum, and Other which includes businesses that do not meet the separately reportable segment thresholds.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:29.25pt">The Company's Infrastructure segment is comprised of DBM Global Inc. ("DBMG") and its wholly-owned subsidiaries. DBMG is a fully integrated industrial construction, structural steel and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services and also fabricates trusses and girders and specializes in the fabrication and erection of large-diameter water pipe and water storage tanks, as well as 3-D Building Information Modeling (“BIM”) and detailing. DBMG provides these services on commercial, industrial, and infrastructure construction projects such as high- and low-rise buildings and office complexes, hotels and casinos, convention centers, sports arenas and stadiums, shopping malls, hospitals, dams, bridges, mines, metal processing, refineries, pulp and paper mills and power plants. Through GrayWolf Industrial Inc. ("GrayWolf"), DBMG provides integrated solutions for digital engineering, modeling and detailing, construction, heavy equipment installation and facility services including maintenance, repair, and installation to a diverse range of end markets. Through Aitken Manufacturing, Inc., DBMG manufactures pollution control scrubbers, tunnel liners, pressure vessels, strainers, filters, separators and a variety of customized products. Through Banker Steel, a division of Schuff Steel Company, DBMG provides full-service fabricated structural steel and erection services primarily for the U.S. East Coast and Southeast commercial and industrial construction markets, in addition to full design-assist services. The Company maintains a 91.2% controlling interest in DBMG.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:29.25pt">The Company's Life Sciences segment is comprised of Pansend Life Sciences, LLC ("Pansend"), its subsidiaries and its equity investments. Pansend maintains controlling interests of 80.0% in Genovel Orthopedics, Inc. ("Genovel"), which seeks to develop products to treat early osteoarthritis of the knee and 81.4% in R2 Technologies, Inc. ("R2 Technologies") (56.6% as of December 31, 2023), which develops aesthetic and medical technologies for the skin. Pansend also invests in other early stage or developmental stage healthcare companies and, as of June 30, 2024, had a 46.0% interest in MediBeacon Inc. ("MediBeacon"), a medical technology company specializing in the advances of fluorescent tracer agents and transdermal measurement, potentially enabling real-time, direct monitoring of kidney function, a 1.9% fully diluted interest in Triple Ring Technologies, Inc. ("Triple Ring"), a science and technology co-development company, and a 20.1% interest in Scaled Cell Solutions, Inc. ("Scaled Cell"), an immunotherapy company developing a novel autologous cell therapy system to potentially improve current CAR-T treatments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:29.25pt">The Company's Spectrum segment is comprised of HC2 Broadcasting Holdings Inc. ("Broadcasting") and its subsidiaries. Broadcasting strategically acquired and operates over-the-air broadcasting stations across the United States. The Company maintains a 98.0% controlling interest in Broadcasting and maintains a controlling interest of approximately 69.2%, inclusive of 2.8% proxy rights from minority holders of DTV America Corporation ("DTV"). On a fully diluted basis, the Company would have an 85.8% controlling interest in Broadcasting.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:29.25pt">The Company's Other segment represents all other businesses or investments that do not meet the definition of a segment individually or in the aggregate. Included in the Other segment is TIC Holdco, Inc. ("TIC"), and the former Marine Services segment, which includes its holding company, Global Marine Holdings, LLC ("GMH"), in which the Company maintains a 72.8% controlling interest. GMH's prior period results included its subsidiary's prior 19.0% equity method investment in HMN International Co., Ltd., formerly known as Huawei Marine Networks Co. (“HMN”), until it was sold on March 6, 2023. Refer to Note 6. Investments for additional information.</span></div>
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	35000000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:115%">Use of Estimates and Assumptions</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of the Company’s unaudited Condensed Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and assumptions used.</span></div>
CY2024Q2	us-gaap	Revenues Revenues	313100000	usd
CY2023Q2	us-gaap	Revenues Revenues	368800000	usd
	us-gaap	Revenues Revenues	628300000	usd
	us-gaap	Revenues Revenues	686700000	usd
CY2024Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	173200000	usd
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	273200000	usd
CY2023Q1	us-gaap	Contract With Customer Receivable After Allowance For Credit Loss Current ContractWithCustomerReceivableAfterAllowanceForCreditLossCurrent	250400000	usd
CY2024Q2	vate	Costs Incurred On Contracts In Progress CostsIncurredOnContractsInProgress	3000500000	usd
CY2023Q4	vate	Costs Incurred On Contracts In Progress CostsIncurredOnContractsInProgress	2811800000	usd
CY2024Q2	vate	Estimated Earnings On Contracts EstimatedEarningsOnContracts	638800000	usd
CY2023Q4	vate	Estimated Earnings On Contracts EstimatedEarningsOnContracts	510100000	usd
CY2024Q2	vate	Cost Earned On Uncompleted Contracts Gross CostEarnedOnUncompletedContractsGross	3639300000	usd
CY2023Q4	vate	Cost Earned On Uncompleted Contracts Gross CostEarnedOnUncompletedContractsGross	3321900000	usd
CY2024Q2	vate	Progress Billing On Contract ProgressBillingOnContract	3610900000	usd
CY2023Q4	vate	Progress Billing On Contract ProgressBillingOnContract	3356800000	usd
CY2024Q2	vate	Cost Earned On Uncompleted Contracts Net CostEarnedOnUncompletedContractsNet	28400000	usd
CY2023Q4	vate	Cost Earned On Uncompleted Contracts Net CostEarnedOnUncompletedContractsNet	-34900000	usd
CY2024Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	101200000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	118600000	usd
CY2024Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	72800000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	153500000	usd
CY2024Q2	vate	Contract With Customer Net Asset Liability ContractWithCustomerNetAssetLiability	28400000	usd
CY2023Q4	vate	Contract With Customer Net Asset Liability ContractWithCustomerNetAssetLiability	-34900000	usd
CY2024Q2	us-gaap	Construction In Progress Gross ConstructionInProgressGross	171000000.0	usd
CY2023Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	271700000	usd
CY2024Q2	us-gaap	Accounts Receivable Gross AccountsReceivableGross	2300000	usd
CY2023Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	1900000	usd
CY2024Q2	us-gaap	Other Receivables OtherReceivables	5000000.0	usd
CY2023Q4	us-gaap	Other Receivables OtherReceivables	5200000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	100000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	400000	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	178200000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	278400000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	254900000	usd
CY2024Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	19700000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	21000000.0	usd
CY2024Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	400000	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	600000	usd
CY2024Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	800000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	800000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	20900000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	22400000	usd
CY2024Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1100000	usd
CY2023Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-300000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2300000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-4300000	usd
CY2024Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	291000000.0	usd
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	292300000	usd
CY2024Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	147300000	usd
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	137700000	usd
CY2024Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	143700000	usd
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	154600000	usd
CY2024Q2	us-gaap	Depreciation Depreciation	6400000	usd
CY2023Q2	us-gaap	Depreciation Depreciation	6200000	usd
CY2024Q2	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	3900000	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	4100000	usd
	us-gaap	Depreciation Depreciation	12900000	usd
	us-gaap	Depreciation Depreciation	12500000	usd
	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	7900000	usd
	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	8000000.0	usd
CY2024Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	700000	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	2300000	usd
CY2023Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	3100000	usd
CY2023Q4	vate	Disposal Group Including Discontinued Operation Number Of Buildings Held For Sale DisposalGroupIncludingDiscontinuedOperationNumberOfBuildingsHeldForSale	2	building
CY2023Q4	us-gaap	Goodwill Goodwill	127100000	usd
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-100000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	127000000.0	usd
CY2024Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	106300000	usd
CY2023Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	106300000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	129300000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	60500000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	68800000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	129300000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	56700000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	72600000	usd
CY2024Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1900000	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3400000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3800000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7400000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	48400000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	58000000.0	usd
CY2024Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	700000	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	2300000	usd
CY2024Q2	vate	Lease Right Of Use Asset LeaseRightOfUseAsset	49100000	usd
CY2023Q4	vate	Lease Right Of Use Asset LeaseRightOfUseAsset	60300000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	12300000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	13500000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	39000000.0	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	48600000	usd
CY2024Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	800000	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	2400000	usd
CY2024Q2	vate	Lease Liability LeaseLiability	52100000	usd
CY2023Q4	vate	Lease Liability LeaseLiability	64500000	usd
CY2024Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	100000	usd
CY2023Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	100000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	200000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	200000	usd
CY2024Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	0	usd
CY2023Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	100000	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	0	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	100000	usd
CY2024Q2	vate	Finance Lease Cost FinanceLeaseCost	100000	usd
CY2023Q2	vate	Finance Lease Cost FinanceLeaseCost	200000	usd
	vate	Finance Lease Cost FinanceLeaseCost	200000	usd
	vate	Finance Lease Cost FinanceLeaseCost	300000	usd
CY2024Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	4400000	usd
CY2023Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	5700000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	8900000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	11600000	usd
CY2024Q2	us-gaap	Variable Lease Cost VariableLeaseCost	200000	usd
CY2023Q2	us-gaap	Variable Lease Cost VariableLeaseCost	200000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	300000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	300000	usd
CY2024Q2	us-gaap	Sublease Income SubleaseIncome	200000	usd
CY2023Q2	us-gaap	Sublease Income SubleaseIncome	200000	usd
	us-gaap	Sublease Income SubleaseIncome	400000	usd
	us-gaap	Sublease Income SubleaseIncome	400000	usd
CY2024Q2	us-gaap	Lease Cost LeaseCost	4500000	usd
CY2023Q2	us-gaap	Lease Cost LeaseCost	5900000	usd
	us-gaap	Lease Cost LeaseCost	9000000.0	usd
	us-gaap	Lease Cost LeaseCost	11800000	usd
CY2024Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	4800000	usd
CY2023Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	5700000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	9800000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	12000000.0	usd
CY2024Q2	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	0	usd
CY2023Q2	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	100000	usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	0	usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	100000	usd
CY2024Q2	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	100000	usd
CY2023Q2	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	100000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	200000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	200000	usd
CY2024Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3600000	usd
CY2023Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	600000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	6200000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	4500000	usd
CY2024Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
CY2023Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	600000	usd
CY2024Q2	vate	Operating Lease Modification Incentive OperatingLeaseModificationIncentive	4000000	usd
	vate	Operating Lease Modification Incentive OperatingLeaseModificationIncentive	4000000	usd
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y3M18D
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y6M
CY2024Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y10M24D
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y7M6D
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.059
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.056
CY2024Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.054
CY2023Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.068
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	7900000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	200000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	12900000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	300000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	9300000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	200000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	6600000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	200000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	4800000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	0	usd
CY2024Q2	vate	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	21500000	usd
CY2024Q2	vate	Finance Lease Liability To Be Paid After Year Four FinanceLeaseLiabilityToBePaidAfterYearFour	0	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	63000000.0	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	900000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	11700000	usd
CY2024Q2	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	100000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	51300000	usd
CY2024Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	800000	usd
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	8000000.0	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	11200000	usd
CY2024Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	2900000	usd
CY2023Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	2100000	usd
CY2024Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	900000	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	900000	usd
CY2024Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	2600000	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	400000	usd
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	14400000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	14600000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	48400000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	58000000.0	usd
CY2024Q2	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	600000	usd
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	600000	usd
CY2024Q2	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	5500000	usd
CY2023Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	2700000	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	54500000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	61300000	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	12400000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	14300000	usd
CY2024Q2	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	29900000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	29200000	usd
CY2024Q2	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	16700000	usd
CY2023Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	17100000	usd
CY2024Q2	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	200000	usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	9800000	usd
CY2024Q2	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	900000	usd
CY2023Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	400000	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	60100000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	70800000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	12300000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	13500000	usd
CY2024Q2	vate	Other Liabilities Current Other OtherLiabilitiesCurrentOther	3500000	usd
CY2023Q4	vate	Other Liabilities Current Other OtherLiabilitiesCurrentOther	2600000	usd
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	15800000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	16100000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	39000000.0	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	48600000	usd
CY2024Q2	vate	Interest Payable And Exit Fees Noncurrent InterestPayableAndExitFeesNoncurrent	35500000	usd
CY2023Q4	vate	Interest Payable And Exit Fees Noncurrent InterestPayableAndExitFeesNoncurrent	30800000	usd
CY2024Q2	vate	Other Liabilities Noncurrent Other OtherLiabilitiesNoncurrentOther	2700000	usd
CY2023Q4	vate	Other Liabilities Noncurrent Other OtherLiabilitiesNoncurrentOther	3300000	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	77200000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	82700000	usd
CY2024Q2	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	698000000.0	usd
CY2023Q4	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	722800000	usd
CY2024Q2	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	9500000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	13000000.0	usd
CY2024Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	50200000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	30500000	usd
CY2024Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	638300000	usd
CY2023Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	679300000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	200000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	52900000	usd
CY2024Q2	vate	Long Term Debt And Lease Obligations Maturities Repayments Of Principal Remainder Of Year LongTermDebtAndLeaseObligationsMaturitiesRepaymentsOfPrincipalRemainderOfYear	53100000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	300000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	241600000	usd
CY2024Q2	vate	Long Term Debt And Lease Obligations Maturities Repayments Of Principal In Year One LongTermDebtAndLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearOne	241900000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	200000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	511500000	usd
CY2024Q2	vate	Long Term Debt And Lease Obligations Maturities Repayments Of Principal In Year Two LongTermDebtAndLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo	511700000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	200000	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	usd
CY2024Q2	vate	Long Term Debt And Lease Obligations Maturities Repayments Of Principal In Year Three LongTermDebtAndLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree	200000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	900000	usd
CY2024Q2	vate	Debt Including Interest Payable DebtIncludingInterestPayable	806000000.0	usd
CY2024Q2	vate	Long Term Debt And Lease Obligation Including Current Maturities And Interest LongTermDebtAndLeaseObligationIncludingCurrentMaturitiesAndInterest	806900000	usd
CY2024Q2	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	100000	usd
CY2024Q2	vate	Long Term Debt Maturities Interest Included In Payments LongTermDebtMaturitiesInterestIncludedInPayments	108800000	usd
CY2024Q2	vate	Long Term Debt And Lease Obligations Maturities Interest Included In Payments LongTermDebtAndLeaseObligationsMaturitiesInterestIncludedInPayments	108900000	usd
CY2024Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	800000	usd
CY2024Q2	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	697200000	usd
CY2024Q2	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	698000000.0	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2500000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1200000	usd
	vate	Income Tax Expense Benefit Interim Tax IncomeTaxExpenseBenefitInterimTax	1100000	usd
CY2023Q2	vate	Income Tax Expense Benefit Interim Tax IncomeTaxExpenseBenefitInterimTax	1100000	usd
	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	58700000	usd
	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	58700000	usd
CY2024Q1	vate	Number Of Causes Of Action Against Hc2 And Innovate NumberOfCausesOfActionAgainstHC2AndInnovate	1	causeofaction
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	400000	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	700000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	800000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4995150	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.02
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	352339	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	3.12
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4642811	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.17
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	4465491	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	5.20
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	177320	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.32
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y1M6D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	0	shares
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	0	usd
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	160000000	shares
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	35000000	usd
	vate	Preferred Stock Consent Rights Percentage PreferredStockConsentRightsPercentage	0.049
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2024Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	100000	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	0	usd
	vate	Number Of Geographic Reportable Segments NumberOfGeographicReportableSegments	1	segment
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	313100000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	368800000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	628300000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	686700000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	28800000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	5800000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	31600000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	1800000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	28800000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	5800000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	31600000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	1800000	usd
CY2024Q2	us-gaap	Interest Expense Operating InterestExpenseOperating	16500000	usd
CY2023Q2	us-gaap	Interest Expense Operating InterestExpenseOperating	16300000	usd
	us-gaap	Interest Expense Operating InterestExpenseOperating	33700000	usd
	us-gaap	Interest Expense Operating InterestExpenseOperating	31900000	usd
CY2024Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1100000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-4300000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	300000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1000000.0	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	16800000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	11400000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10500000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5400000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-17600000	usd
CY2024Q2	us-gaap	Investments Investments	1800000	usd
CY2023Q4	us-gaap	Investments Investments	1800000	usd
CY2024Q2	us-gaap	Assets Assets	898900000	usd
CY2023Q4	us-gaap	Assets Assets	1043600000	usd
CY2023Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2024Q2	us-gaap	Profit Loss ProfitLoss	13900000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-11700000	usd
	us-gaap	Profit Loss ProfitLoss	-6200000	usd
	us-gaap	Profit Loss ProfitLoss	-19700000	usd
CY2024Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-500000	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1800000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-3200000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-800000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	14400000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-9900000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3000000.0	usd
	us-gaap	Net Income Loss NetIncomeLoss	-18900000	usd
CY2024Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	300000	usd
CY2023Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	600000	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	600000	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1800000	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	14100000	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	14100000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10500000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-10500000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3600000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-3600000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-20700000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-20700000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	89204850	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77922241	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	83929228	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77806010	shares
CY2024Q2	vate	Incremental Common Shares Attributableto Dilutive Effectof Conversionof Restricted Stock IncrementalCommonSharesAttributabletoDilutiveEffectofConversionofRestrictedStock	1122921	shares
CY2023Q2	vate	Incremental Common Shares Attributableto Dilutive Effectof Conversionof Restricted Stock IncrementalCommonSharesAttributabletoDilutiveEffectofConversionofRestrictedStock	0	shares
	vate	Incremental Common Shares Attributableto Dilutive Effectof Conversionof Restricted Stock IncrementalCommonSharesAttributabletoDilutiveEffectofConversionofRestrictedStock	0	shares
	vate	Incremental Common Shares Attributableto Dilutive Effectof Conversionof Restricted Stock IncrementalCommonSharesAttributabletoDilutiveEffectofConversionofRestrictedStock	0	shares
CY2024Q2	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	36530623	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	0	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	19050241	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	0	shares
CY2024Q2	vate	Participating Securities Including Common Stock Shares ParticipatingSecuritiesIncludingCommonStockShares	126858394	shares
CY2023Q2	vate	Participating Securities Including Common Stock Shares ParticipatingSecuritiesIncludingCommonStockShares	77922241	shares
	vate	Participating Securities Including Common Stock Shares ParticipatingSecuritiesIncludingCommonStockShares	102979469	shares
	vate	Participating Securities Including Common Stock Shares ParticipatingSecuritiesIncludingCommonStockShares	77806010	shares
CY2024Q2	vate	Percentageof Loss Allocatedto Common Stock PercentageofLossAllocatedtoCommonStock	0.703
CY2023Q2	vate	Percentageof Loss Allocatedto Common Stock PercentageofLossAllocatedtoCommonStock	1.000
	vate	Percentageof Loss Allocatedto Common Stock PercentageofLossAllocatedtoCommonStock	0.815
	vate	Percentageof Loss Allocatedto Common Stock PercentageofLossAllocatedtoCommonStock	1.000
CY2024Q2	vate	Percentageof Loss Allocatedto Unvested Restricted Stock PercentageofLossAllocatedtoUnvestedRestrictedStock	0.009
CY2023Q2	vate	Percentageof Loss Allocatedto Unvested Restricted Stock PercentageofLossAllocatedtoUnvestedRestrictedStock	0
	vate	Percentageof Loss Allocatedto Unvested Restricted Stock PercentageofLossAllocatedtoUnvestedRestrictedStock	0
	vate	Percentageof Loss Allocatedto Unvested Restricted Stock PercentageofLossAllocatedtoUnvestedRestrictedStock	0
CY2024Q2	vate	Percentageof Loss Allocatedto Preferred Stock PercentageofLossAllocatedtoPreferredStock	0.288
CY2023Q2	vate	Percentageof Loss Allocatedto Preferred Stock PercentageofLossAllocatedtoPreferredStock	0
	vate	Percentageof Loss Allocatedto Preferred Stock PercentageofLossAllocatedtoPreferredStock	0.185
	vate	Percentageof Loss Allocatedto Preferred Stock PercentageofLossAllocatedtoPreferredStock	0
CY2024Q2	us-gaap	Undistributed Earnings Loss Available To Common Shareholders Basic UndistributedEarningsLossAvailableToCommonShareholdersBasic	9900000	usd
CY2023Q2	us-gaap	Undistributed Earnings Loss Available To Common Shareholders Basic UndistributedEarningsLossAvailableToCommonShareholdersBasic	-10500000	usd
	us-gaap	Undistributed Earnings Loss Available To Common Shareholders Basic UndistributedEarningsLossAvailableToCommonShareholdersBasic	-2900000	usd
	us-gaap	Undistributed Earnings Loss Available To Common Shareholders Basic UndistributedEarningsLossAvailableToCommonShareholdersBasic	-20700000	usd
CY2024Q2	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	4900000	usd
CY2023Q2	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	0	usd
	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	0	usd
	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	0	usd
CY2024Q2	us-gaap	Undistributed Earnings Loss Available To Common Shareholders Diluted UndistributedEarningsLossAvailableToCommonShareholdersDiluted	14800000	usd
CY2023Q2	us-gaap	Undistributed Earnings Loss Available To Common Shareholders Diluted UndistributedEarningsLossAvailableToCommonShareholdersDiluted	-10500000	usd
	us-gaap	Undistributed Earnings Loss Available To Common Shareholders Diluted UndistributedEarningsLossAvailableToCommonShareholdersDiluted	-2900000	usd
	us-gaap	Undistributed Earnings Loss Available To Common Shareholders Diluted UndistributedEarningsLossAvailableToCommonShareholdersDiluted	-20700000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	89204850	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77922241	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	83929228	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77806010	shares
CY2024Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	55052702	shares
CY2023Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	144257552	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77922241	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	83929228	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77806010	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.11
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.27
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.10
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.27
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	80800000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	80400000	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	900000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	300000	usd
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	600000	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1500000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	82300000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	82200000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	80200000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	28800000	usd
CY2024Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	900000	usd
CY2023Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	usd
CY2024Q2	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	600000	usd
CY2023Q2	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1400000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	81700000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	30200000	usd
	us-gaap	Interest Paid Net InterestPaidNet	22700000	usd
	us-gaap	Interest Paid Net InterestPaidNet	23700000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	600000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	6000000.0	usd
	vate	Debt Issuance In Connection With Preferred Stock Purchase And Dividend Payments DebtIssuanceInConnectionWithPreferredStockPurchaseAndDividendPayments	0	usd
	vate	Debt Issuance In Connection With Preferred Stock Purchase And Dividend Payments DebtIssuanceInConnectionWithPreferredStockPurchaseAndDividendPayments	35100000	usd
	vate	Fees And Interest Capitalized FeesAndInterestCapitalized	4300000	usd
	vate	Fees And Interest Capitalized FeesAndInterestCapitalized	0	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1200000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1500000	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001006837-24-000122-index-headers.html	Edgar Link	pending
0001006837-24-000122-index.html	Edgar Link	pending
0001006837-24-000122.txt	Edgar Link	pending
0001006837-24-000122-xbrl.zip	Edgar Link	pending
exh106exhathirdamendment001.jpg	Edgar Link	pending
exh106exhathirdamendment002.jpg	Edgar Link	pending
exh106exhathirdamendment003.jpg	Edgar Link	pending
exh106exhathirdamendment004.jpg	Edgar Link	pending
exh106exhathirdamendment005.jpg	Edgar Link	pending
exh106exhathirdamendment006.jpg	Edgar Link	pending
exh106exhathirdamendment007.jpg	Edgar Link	pending
exh106exhathirdamendment008.jpg	Edgar Link	pending
exh106exhathirdamendment009.jpg	Edgar Link	pending
exh106exhathirdamendment010.jpg	Edgar Link	pending
exh106exhathirdamendment011.jpg	Edgar Link	pending
exh106exhathirdamendment012.jpg	Edgar Link	pending
exh106exhathirdamendment013.jpg	Edgar Link	pending
exh106exhathirdamendment014.jpg	Edgar Link	pending
exh106exhathirdamendment015.jpg	Edgar Link	pending
exh106exhathirdamendment016.jpg	Edgar Link	pending
exh106exhathirdamendment017.jpg	Edgar Link	pending
exh106exhathirdamendment018.jpg	Edgar Link	pending
exh106exhathirdamendment019.jpg	Edgar Link	pending
exh106exhathirdamendment020.jpg	Edgar Link	pending
exh106exhathirdamendment021.jpg	Edgar Link	pending
exh106exhathirdamendment022.jpg	Edgar Link	pending
exh106exhathirdamendment023.jpg	Edgar Link	pending
exh106exhathirdamendment024.jpg	Edgar Link	pending
exh106exhathirdamendment025.jpg	Edgar Link	pending
exh106exhathirdamendment026.jpg	Edgar Link	pending
exh106exhathirdamendment027.jpg	Edgar Link	pending
exh106exhathirdamendment028.jpg	Edgar Link	pending
exh106exhathirdamendment029.jpg	Edgar Link	pending
exh106exhathirdamendment030.jpg	Edgar Link	pending
exh106exhathirdamendment031.jpg	Edgar Link	pending
exh106exhathirdamendment032.jpg	Edgar Link	pending
exh106exhathirdamendment033.jpg	Edgar Link	pending
exh106exhathirdamendment034.jpg	Edgar Link	pending
exh106exhathirdamendment035.jpg	Edgar Link	pending
exh106exhathirdamendment036.jpg	Edgar Link	pending
exh106exhathirdamendment037.jpg	Edgar Link	pending
exh106exhathirdamendment038.jpg	Edgar Link	pending
exh106exhathirdamendment039.jpg	Edgar Link	pending
exh106exhathirdamendment040.jpg	Edgar Link	pending
exh106exhathirdamendment041.jpg	Edgar Link	pending
exh106exhathirdamendment042.jpg	Edgar Link	pending
exh106exhathirdamendment043.jpg	Edgar Link	pending
exh106exhathirdamendment044.jpg	Edgar Link	pending
exh106exhathirdamendment045.jpg	Edgar Link	pending
exh106exhathirdamendment046.jpg	Edgar Link	pending
exh106exhathirdamendment047.jpg	Edgar Link	pending
exh106exhathirdamendment048.jpg	Edgar Link	pending
exh106exhathirdamendment049.jpg	Edgar Link	pending
exh106exhathirdamendment050.jpg	Edgar Link	pending
exh106exhathirdamendment051.jpg	Edgar Link	pending
exh106exhathirdamendment052.jpg	Edgar Link	pending
exh106exhathirdamendment053.jpg	Edgar Link	pending
exh106exhathirdamendment054.jpg	Edgar Link	pending
exh106exhathirdamendment055.jpg	Edgar Link	pending
exh106exhathirdamendment056.jpg	Edgar Link	pending
exh106exhathirdamendment057.jpg	Edgar Link	pending
exh106exhathirdamendment058.jpg	Edgar Link	pending
exh106exhathirdamendment059.jpg	Edgar Link	pending
exh106exhathirdamendment060.jpg	Edgar Link	pending
exh106exhathirdamendment061.jpg	Edgar Link	pending
exh106exhathirdamendment062.jpg	Edgar Link	pending
exh106exhathirdamendment063.jpg	Edgar Link	pending
exh106exhathirdamendment064.jpg	Edgar Link	pending
exh106exhathirdamendment065.jpg	Edgar Link	pending
exh106exhathirdamendment066.jpg	Edgar Link	pending
exh106exhathirdamendment067.jpg	Edgar Link	pending
exh106exhathirdamendment068.jpg	Edgar Link	pending
exh106exhathirdamendment069.jpg	Edgar Link	pending
exh106exhathirdamendment070.jpg	Edgar Link	pending
exh106exhathirdamendment071.jpg	Edgar Link	pending
exh106exhathirdamendment072.jpg	Edgar Link	pending
exh106exhathirdamendment073.jpg	Edgar Link	pending
exh106exhathirdamendment074.jpg	Edgar Link	pending
exh106exhathirdamendment075.jpg	Edgar Link	pending
exh106exhathirdamendment076.jpg	Edgar Link	pending
exh106exhathirdamendment077.jpg	Edgar Link	pending
exh106exhathirdamendment078.jpg	Edgar Link	pending
exh106exhathirdamendment079.jpg	Edgar Link	pending
exh106exhathirdamendment080.jpg	Edgar Link	pending
exh106exhathirdamendment081.jpg	Edgar Link	pending
exh106exhathirdamendment082.jpg	Edgar Link	pending
exh106exhathirdamendment083.jpg	Edgar Link	pending
exh106exhathirdamendment084.jpg	Edgar Link	pending
exh106exhathirdamendment085.jpg	Edgar Link	pending
exh106exhathirdamendment086.jpg	Edgar Link	pending
exh106exhathirdamendment087.jpg	Edgar Link	pending
exh106exhathirdamendment088.jpg	Edgar Link	pending
exh106exhathirdamendment089.jpg	Edgar Link	pending
exh106exhathirdamendment090.jpg	Edgar Link	pending
exh106exhathirdamendment091.jpg	Edgar Link	pending
exh106exhathirdamendment092.jpg	Edgar Link	pending
exh106exhathirdamendment093.jpg	Edgar Link	pending
exh106exhathirdamendment094.jpg	Edgar Link	pending
exh106exhathirdamendment095.jpg	Edgar Link	pending
exh106exhathirdamendment096.jpg	Edgar Link	pending
exh106exhathirdamendment097.jpg	Edgar Link	pending
exh106exhathirdamendment098.jpg	Edgar Link	pending
exh106exhathirdamendment099.jpg	Edgar Link	pending
exh106exhathirdamendment100.jpg	Edgar Link	pending
exh106exhathirdamendment101.jpg	Edgar Link	pending
exh106exhathirdamendment102.jpg	Edgar Link	pending
exh106exhathirdamendment103.jpg	Edgar Link	pending
exh106exhathirdamendment104.jpg	Edgar Link	pending
exh106exhathirdamendment105.jpg	Edgar Link	pending
exh106exhathirdamendment106.jpg	Edgar Link	pending
exh106exhathirdamendment107.jpg	Edgar Link	pending
exh106exhathirdamendment108.jpg	Edgar Link	pending
exh106exhathirdamendment109.jpg	Edgar Link	pending
exh106exhathirdamendment110.jpg	Edgar Link	pending
exh106exhathirdamendment111.jpg	Edgar Link	pending
exh106exhathirdamendment112.jpg	Edgar Link	pending
exh106exhathirdamendment113.jpg	Edgar Link	pending
exh106exhathirdamendment114.jpg	Edgar Link	pending
exh106exhathirdamendment115.jpg	Edgar Link	pending
exh106exhathirdamendment116.jpg	Edgar Link	pending
exh106exhathirdamendment117.jpg	Edgar Link	pending
exh106exhathirdamendment118.jpg	Edgar Link	pending
exh106exhathirdamendment119.jpg	Edgar Link	pending
exh106exhathirdamendment120.jpg	Edgar Link	pending
exh106exhathirdamendment121.jpg	Edgar Link	pending
exh106exhathirdamendment122.jpg	Edgar Link	pending
exh106exhathirdamendment123.jpg	Edgar Link	pending
exh106exhathirdamendment124.jpg	Edgar Link	pending
exh106exhathirdamendment125.jpg	Edgar Link	pending
exh106exhathirdamendment126.jpg	Edgar Link	pending
exh106exhathirdamendment127.jpg	Edgar Link	pending
exh106exhathirdamendment128.jpg	Edgar Link	pending
exh106exhathirdamendment129.jpg	Edgar Link	pending
exh106exhathirdamendment130.jpg	Edgar Link	pending
exh106exhathirdamendment131.jpg	Edgar Link	pending
exh106exhathirdamendment132.jpg	Edgar Link	pending
exh106exhathirdamendment133.jpg	Edgar Link	pending
exh106exhathirdamendment134.jpg	Edgar Link	pending
exh106exhathirdamendment135.jpg	Edgar Link	pending
exh106exhathirdamendment136.jpg	Edgar Link	pending
exh106exhathirdamendment137.jpg	Edgar Link	pending
exh106exhathirdamendment138.jpg	Edgar Link	pending
exh106exhathirdamendment139.jpg	Edgar Link	pending
exh106exhathirdamendment140.jpg	Edgar Link	pending
exh106exhathirdamendment141.jpg	Edgar Link	pending
exh106exhathirdamendment142.jpg	Edgar Link	pending
exh106exhathirdamendment143.jpg	Edgar Link	pending
exh106exhathirdamendment144.jpg	Edgar Link	pending
exh106exhathirdamendment145.jpg	Edgar Link	pending
exh106exhathirdamendment146.jpg	Edgar Link	pending
exh106exhathirdamendment147.jpg	Edgar Link	pending
exh106exhathirdamendment148.jpg	Edgar Link	pending
exh106exhathirdamendment149.jpg	Edgar Link	pending
exh106exhathirdamendment150.jpg	Edgar Link	pending
exh106exhathirdamendment151.jpg	Edgar Link	pending
exh106exhathirdamendment152.jpg	Edgar Link	pending
exh106exhathirdamendment153.jpg	Edgar Link	pending
exh106exhathirdamendment154.jpg	Edgar Link	pending
exh106exhathirdamendment155.jpg	Edgar Link	pending
exhibit103-q210q2024.htm	Edgar Link	pending
exhibit104-q210q2024.htm	Edgar Link	pending
exhibit105-q210q2024.htm	Edgar Link	pending
exhibit106-q22024combined.htm	Edgar Link	pending
exhibit107q2202410-q.htm	Edgar Link	pending
exhibit311-q210q2024.htm	Edgar Link	pending
exhibit312-q210q2024.htm	Edgar Link	pending
exhibit321-q210q2024.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vate-20240630.htm	Edgar Link	pending
vate-20240630.xsd	Edgar Link	pending
vate-20240630_g1.jpg	Edgar Link	pending
vate-20240630_cal.xml	Edgar Link	unprocessable
vate-20240630_def.xml	Edgar Link	unprocessable
vate-20240630_lab.xml	Edgar Link	unprocessable
vate-20240630_pre.xml	Edgar Link	unprocessable
vate-20240630_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VATE
INNOVATE Corp. Stock $vate

2024 Q3 Form 10-Q Financial Statement

#000100683724000122 Filed on August 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VATE INNOVATE Corp. Stock $vate

2024 Q3 Form 10-Q Financial Statement

#000100683724000122 Filed on August 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VATE
INNOVATE Corp. Stock $vate